{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T00:38:22Z","timestamp":1790469502392,"version":"4.1.0"},"reference-count":206,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2009,1,1]],"date-time":"2009-01-01T00:00:00Z","timestamp":1230768000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,1,1]],"date-time":"2009-01-01T00:00:00Z","timestamp":1230768000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Hematology"],"published-print":{"date-parts":[[2009,1]]},"DOI":"10.1053\/j.seminhematol.2008.12.003","type":"journal-article","created":{"date-parts":[[2009,2,25]],"date-time":"2009-02-25T04:42:52Z","timestamp":1235536972000},"page":"S44-S58","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"S2","title":["Therapeutic Approaches to Secondary Immune Thrombocytopenic Purpura"],"prefix":"10.1053","volume":"46","author":[{"given":"James B.","family":"Bussel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1053\/j.seminhematol.2008.12.003_bib1","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1056\/NEJM198105073041904","article-title":"Chronic idiopathic thrombocytopenic purpura","volume":"304","author":"McMillan","year":"1981","journal-title":"N Engl J Med"},{"key":"10.1053\/j.seminhematol.2008.12.003_bib2","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1055\/s-2007-1005045","article-title":"Autoimmune platelet destruction: idiopathic thrombocytopenic purpura","volume":"8","author":"Kelton","year":"1982","journal-title":"Semin Thromb Hemost"},{"key":"10.1053\/j.seminhematol.2008.12.003_bib3","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/j.hoc.2007.06.007","article-title":"Immune thrombocytopenic purpura","volume":"21","author":"Psaila","year":"2007","journal-title":"Hematol Oncol Clin North Am"},{"key":"10.1053\/j.seminhematol.2008.12.003_bib4","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1172\/JCI113060","article-title":"Mechanisms of thrombocytopenia in chronic autoimmune thrombocytopenic purpura","volume":"80","author":"Ballem","year":"1987","journal-title":"J Clin Invest"},{"key":"10.1053\/j.seminhematol.2008.12.003_bib5","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1038\/nm921","article-title":"T-cell-mediated cytotoxicity toward platelets in chronic idiopathic thrombocytopenic purpura","volume":"9","author":"Olsson","year":"2003","journal-title":"Nat Med"},{"key":"10.1053\/j.seminhematol.2008.12.003_bib6","doi-asserted-by":"crossref","first-page":"2705","DOI":"10.1182\/blood-2003-10-3552","article-title":"IgG antiplatelet immunity is dependent on an early innate natural killer cell-derived interferon-gamma response that is regulated by CD8+ T cells","volume":"103","author":"Sayeh","year":"2004","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2008.12.003_bib7","doi-asserted-by":"crossref","first-page":"2645","DOI":"10.1182\/blood-2003-07-2268","article-title":"Adult chronic idiopathic thrombocytopenic purpura (ITP) is the manifestation of a type-1 polarized immune response","volume":"103","author":"Panitsas","year":"2004","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2008.12.003_bib8","doi-asserted-by":"crossref","first-page":"2244","DOI":"10.1182\/blood-2004-12-4598","article-title":"How I treat idiopathic thrombocytopenic purpura (ITP)","volume":"106","author":"Cines","year":"2005","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2008.12.003_bib9","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1182\/blood.V88.1.3.3","article-title":"Idiopathic thrombocytopenic purpura: a practice guideline developed by explicit methods for the American Society of Hematology","volume":"88","author":"George","year":"1996","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2008.12.003_bib10","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1046\/j.1365-2141.2003.04131.x","article-title":"Guidelines for the investigation and management of idiopathic thrombocytopenic purpura in adults, children and in pregnancy","volume":"120","year":"2003","journal-title":"Br J Haematol"},{"key":"10.1053\/j.seminhematol.2008.12.003_bib11","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1182\/blood-2005-12-015222","article-title":"Therapy with high-dose dexamethasone (HD-DXM) in previously untreated patients affected by idiopathic thrombocytopenic purpura: a GIMEMA experience","volume":"109","author":"Mazzucconi","year":"2007","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2008.12.003_bib12","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1146\/annurev.med.56.082103.104644","article-title":"Management of adult idiopathic thrombocytopenic purpura","volume":"56","author":"Cines","year":"2005","journal-title":"Annu Rev Med"},{"key":"10.1053\/j.seminhematol.2008.12.003_bib13","doi-asserted-by":"crossref","first-page":"3526","DOI":"10.1182\/blood-2007-01-065763","article-title":"Multiagent induction and maintenance therapy for patients with refractory immune thrombocytopenic purpura (ITP)","volume":"110","author":"Boruchov","year":"2007","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2008.12.003_bib14","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1038\/nm1416","article-title":"Intravenous immunoglobulin ameliorates ITP via activating Fc gamma receptors on dendritic cells","volume":"12","author":"Siragam","year":"2006","journal-title":"Nat Med"},{"key":"10.1053\/j.seminhematol.2008.12.003_bib15","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1055\/s-0037-1613331","article-title":"Intravenous immunoglobulin mediates an increase in anti-platelet antibody clearance via the FcRn receptor","volume":"88","author":"Hansen","year":"2002","journal-title":"Thromb Haemost"},{"key":"10.1053\/j.seminhematol.2008.12.003_bib16","doi-asserted-by":"crossref","first-page":"2689","DOI":"10.1182\/blood.V89.8.2689","article-title":"Intravenous anti-D treatment of immune thrombocytopenic purpura: experience in 272 patients","volume":"89","author":"Scaradavou","year":"1997","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2008.12.003_bib17","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1182\/blood.V77.9.1884.1884","article-title":"Intravenous anti-D treatment of immune thrombocytopenic purpura: analysis of efficacy, toxicity, and mechanism of effect","volume":"77","author":"Bussel","year":"1991","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2008.12.003_bib18","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1046\/j.1365-2141.2001.02627.x","article-title":"A dose of 75 microg\/kg\/d of i.v. anti-D increases the platelet count more rapidly and for a longer period of time than 50 microg\/kg\/d in adults with immune thrombocytopenic purpura","volume":"112","author":"Newman","year":"2001","journal-title":"Br J Haematol"},{"key":"10.1053\/j.seminhematol.2008.12.003_bib19","doi-asserted-by":"crossref","first-page":"2523","DOI":"10.1182\/blood.V95.8.2523","article-title":"Acute onset hemoglobinemia and\/or hemoglobinuria and sequelae following Rh(o)(D) immune globulin intravenous administration in immune thrombocytopenic purpura patients","volume":"95","author":"Gaines","year":"2000","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2008.12.003_bib20","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1182\/blood-2004-11-4303","article-title":"Disseminated intravascular coagulation associated with acute hemoglobinemia or hemoglobinuria following Rh(0)(D) immune globulin intravenous administration for immune thrombocytopenic purpura","volume":"106","author":"Gaines","year":"2005","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2008.12.003_bib21","doi-asserted-by":"crossref","first-page":"5527","DOI":"10.1182\/blood-2006-03-004481","article-title":"A closer look at intravascular hemolysis (IVH) following intravenous anti-D for immune thrombocytopenic purpura (ITP)","volume":"109","author":"Tarantino","year":"2007","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2008.12.003_bib22","doi-asserted-by":"crossref","first-page":"2624","DOI":"10.1182\/blood.V91.7.2624","article-title":"Intravenous anti-D treatment for immune thrombocytopenic purpura","volume":"91","author":"Sandler","year":"1998","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2008.12.003_bib23","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1002\/ajh.20813","article-title":"Superior effect of intravenous anti-D compared with IV gammaglobulin in the treatment of HIV-thrombocytopenia: results of a small, randomized prospective comparison","volume":"82","author":"Scaradavou","year":"2007","journal-title":"Am J Hematol"},{"key":"10.1053\/j.seminhematol.2008.12.003_bib24","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1146\/annurev.bi.56.070187.003455","article-title":"Interferons and their actions","volume":"56","author":"Pestka","year":"1987","journal-title":"Annu Rev Biochem"},{"key":"10.1053\/j.seminhematol.2008.12.003_bib25","first-page":"2489","article-title":"Biological properties of recombinant alpha-interferons: 40th anniversary of the discovery of interferons","volume":"58","author":"Pfeffer","year":"1998","journal-title":"Cancer Res"},{"key":"10.1053\/j.seminhematol.2008.12.003_bib26","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1182\/blood.V74.6.1894.1894","article-title":"Improvement of platelet counts in steroid-unresponsive idiopathic immune thrombocytopenic purpura after short-course therapy with recombinant alpha 2b interferon","volume":"74","author":"Proctor","year":"1989","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2008.12.003_bib27","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1111\/j.1600-0609.1994.tb00651.x","article-title":"Interferon treatment of refractory idiopathic thrombocytopenic purpura (ITP)","volume":"52","author":"Dubbeld","year":"1994","journal-title":"Eur J Haematol"},{"key":"10.1053\/j.seminhematol.2008.12.003_bib28","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1002\/ajh.2830430403","article-title":"Alpha-interferon therapy for severe chronic idiopathic thrombocytopenic purpura in children","volume":"43","author":"Cohn","year":"1993","journal-title":"Am J Hematol"},{"key":"10.1053\/j.seminhematol.2008.12.003_bib29","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1111\/j.1399-3038.1993.tb00058.x","article-title":"Increase in platelet count following short course therapy with recombinant alpha-2b-interferon in immune thrombocytopenic purpura in childhood","volume":"4","author":"Behrenbeck","year":"1993","journal-title":"Pediatr Allergy Immunol"},{"key":"10.1053\/j.seminhematol.2008.12.003_bib30","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1002\/ajh.2830380317","article-title":"Continuous, low-dose therapy with interferon-alpha for human immunodeficiency virus (HIV)-related immune thrombocytopenic purpura","volume":"38","author":"Northfelt","year":"1991","journal-title":"Am J Hematol"},{"key":"10.1053\/j.seminhematol.2008.12.003_bib31","first-page":"418","article-title":"Interferon therapy in intravenous drug users with HIV-associated idiopathic thrombocytopenic purpura","volume":"77","author":"Stellini","year":"1992","journal-title":"Haematologica"},{"key":"10.1053\/j.seminhematol.2008.12.003_bib32","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1097\/00002030-199306000-00010","article-title":"Recombinant alpha-interferon 2b in the treatment of HIV-related thrombocytopenia","volume":"7","author":"Vianelli","year":"1993","journal-title":"AIDS"},{"key":"10.1053\/j.seminhematol.2008.12.003_bib33","first-page":"141","article-title":"HIV-related thrombocytopenia: a therapeutical update","volume":"76","author":"Rossi","year":"1991","journal-title":"Haematologica"},{"key":"10.1053\/j.seminhematol.2008.12.003_bib34","doi-asserted-by":"crossref","first-page":"175","DOI":"10.3109\/08916939309077363","article-title":"The effect of a single course of alpha-2B-interferon in patients with HIV-related and chronic idiopathic immune thrombocytopenia","volume":"14","author":"Fabris","year":"1993","journal-title":"Autoimmunity"},{"key":"10.1053\/j.seminhematol.2008.12.003_bib35","first-page":"1146","article-title":"Possible idiopathic thrombocytopenic purpura associated with natural alpha interferon therapy for chronic hepatitis C infection","volume":"90","author":"Shrestha","year":"1995","journal-title":"Am J Gastroenterol"},{"key":"10.1053\/j.seminhematol.2008.12.003_bib36","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1097\/00004836-200401000-00019","article-title":"Possible autoimmune thrombocytopenia associated with pegylated interferon-alpha2a plus ribavarin treatment for hepatitis C","volume":"38","author":"Medeiros","year":"2004","journal-title":"J Clin Gastroenterol"},{"key":"10.1053\/j.seminhematol.2008.12.003_bib37","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1159\/000081276","article-title":"Severe autoimmune thrombocytopenic purpura during interferon-alpha therapy for chronic myelogenous leukemia","volume":"112","author":"Arimura","year":"2004","journal-title":"Acta Haematol"},{"key":"10.1053\/j.seminhematol.2008.12.003_bib38","first-page":"1176","article-title":"Interferon alfa therapy in adults with chronic idiopathic thrombocytopenic purpura","volume":"30","author":"Sekreta","year":"1996","journal-title":"Ann Pharmacother"},{"key":"10.1053\/j.seminhematol.2008.12.003_bib39","doi-asserted-by":"crossref","first-page":"81","DOI":"10.3109\/08916939609001950","article-title":"Effects of interferon-alpha therapy on immune parameters in immune thrombocytopenic purpura","volume":"24","author":"Crossley","year":"1996","journal-title":"Autoimmunity"},{"key":"10.1053\/j.seminhematol.2008.12.003_bib40","first-page":"72","article-title":"Efficacy and safety of splenectomy in immune thrombocytopenic purpura: long-term results of 402 cases","volume":"90","author":"Vianelli","year":"2005","journal-title":"Haematologica"},{"key":"10.1053\/j.seminhematol.2008.12.003_bib41","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/S0002-9343(99)80342-8","article-title":"Long-term observation of 208 adults with chronic idiopathic thrombocytopenic purpura","volume":"98","author":"Stasi","year":"1995","journal-title":"Am J Med"},{"key":"10.1053\/j.seminhematol.2008.12.003_bib42","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1002\/ajh.10253","article-title":"Long term follow-up after splenectomy performed for immune thrombocytopenic purpura (ITP)","volume":"72","author":"Schwartz","year":"2003","journal-title":"Am J Hematol"},{"key":"10.1053\/j.seminhematol.2008.12.003_bib43","doi-asserted-by":"crossref","first-page":"2623","DOI":"10.1182\/blood-2004-03-1168","article-title":"Splenectomy for adult patients with idiopathic thrombocytopenic purpura: a systematic review to assess long-term platelet count responses, prediction of response, and surgical complications","volume":"104","author":"Kojouri","year":"2004","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2008.12.003_bib44","first-page":"1","article-title":"Recommendations of the Advisory Committee on Immunization Practices: use of vaccines and immune globulins in persons with altered immunocompetence","volume":"42","year":"1993","journal-title":"MMWR"},{"key":"10.1053\/j.seminhematol.2008.12.003_bib45","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1046\/j.1198-743x.2001.00355.x","article-title":"Prevention and management of infections in patients without a spleen","volume":"7","author":"Davidson","year":"2001","journal-title":"Clin Microbiol Infect"},{"key":"10.1053\/j.seminhematol.2008.12.003_bib46","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/S0037-1963(00)90105-7","article-title":"Laparoscopic splenectomy in chronic idiopathic thrombocytopenic purpura","volume":"37","author":"Marcaccio","year":"2000","journal-title":"Semin Hematol"},{"key":"10.1053\/j.seminhematol.2008.12.003_bib47","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1046\/j.1365-2141.2001.02615.x","article-title":"Age as the major predictive factor of long-term response to splenectomy in immune thrombocytopenic purpura","volume":"112","author":"Fabris","year":"2001","journal-title":"Br J Haematol"},{"key":"10.1053\/j.seminhematol.2008.12.003_bib48","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1053\/j.seminhematol.2006.04.009","article-title":"Treatment of immune thrombocytopenic purpura in adults","volume":"43","author":"Bussel","year":"2006","journal-title":"Semin Hematol"},{"key":"10.1053\/j.seminhematol.2008.12.003_bib49","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1182\/blood.V98.4.952","article-title":"Rituximab chimeric anti-CD20 monoclonal antibody treatment for adults with chronic idiopathic thrombocytopenic purpura","volume":"98","author":"Stasi","year":"2001","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2008.12.003_bib50","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1111\/j.1365-2141.2004.04889.x","article-title":"The efficacy and safety of B-cell depletion with anti-CD20 monoclonal antibody in adults with chronic immune thrombocytopenic purpura","volume":"125","author":"Cooper","year":"2004","journal-title":"Br J Haematol"},{"key":"10.1053\/j.seminhematol.2008.12.003_bib51","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1053\/j.seminhematol.2006.04.009","article-title":"Treatment of immune thrombocytopenic purpura in adults","volume":"43","author":"Bussel","year":"2006","journal-title":"Semin Hematol"},{"key":"10.1053\/j.seminhematol.2008.12.003_bib52","doi-asserted-by":"crossref","first-page":"2639","DOI":"10.1182\/blood-2005-08-3518","article-title":"Prospective phase 1\/2 study of rituximab in childhood and adolescent chronic immune thrombocytopenic purpura","volume":"107","author":"Bennett","year":"2006","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2008.12.003_bib53","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.jpeds.2004.09.004","article-title":"Chronic immune thrombocytopenic purpura in children: assessment of rituximab treatment","volume":"146","author":"Wang","year":"2005","journal-title":"J Pediatr"},{"key":"10.1053\/j.seminhematol.2008.12.003_bib54","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.1056\/NEJMoa073255","article-title":"Eltrombopag for thrombocytopenia in patients with cirrhosis associated with hepatitis C","volume":"357","author":"McHutchison","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1053\/j.seminhematol.2008.12.003_bib55","doi-asserted-by":"crossref","first-page":"3241","DOI":"10.1182\/blood.V98.12.3241","article-title":"Thrombocytopenia caused by the development of antibodies to thrombopoietin","volume":"98","author":"Li","year":"2001","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2008.12.003_bib56","doi-asserted-by":"crossref","first-page":"2599","DOI":"10.1182\/blood.V99.7.2599","article-title":"Development of pancytopenia with neutralizing antibodies to thrombopoietin after multicycle chemotherapy supported by megakaryocyte growth and development factor","volume":"99","author":"Basser","year":"2002","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2008.12.003_bib57","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1182\/asheducation-2007.1.106","article-title":"Novel thrombopoietic agents","author":"Andemariam","year":"2007","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"10.1053\/j.seminhematol.2008.12.003_bib58","doi-asserted-by":"crossref","first-page":"4607","DOI":"10.1182\/blood-2006-10-019315","article-title":"New thrombopoietic growth factors","volume":"109","author":"Kuter","year":"2007","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2008.12.003_bib59","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.cyto.2003.05.001","article-title":"AMG531 stimulates megakaryopoiesis in vitro by binding to Mpl","volume":"25","author":"Broudy","year":"2004","journal-title":"Cytokine"},{"key":"10.1053\/j.seminhematol.2008.12.003_bib60","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1056\/NEJMoa054626","article-title":"AMG 531, a thrombopoiesis-stimulating protein, for chronic ITP","volume":"355","author":"Bussel","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1053\/j.seminhematol.2008.12.003_bib61","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1111\/j.1365-2141.2006.06339.x","article-title":"An open-label, unit dose-finding study of AMG 531, a novel thrombopoiesis-stimulating peptibody, in patients with immune thrombocytopenic purpura","volume":"135","author":"Newland","year":"2006","journal-title":"Br J Haematol"},{"key":"10.1053\/j.seminhematol.2008.12.003_bib62","doi-asserted-by":"crossref","first-page":"S35","DOI":"10.1053\/j.seminhematol.2007.11.005","article-title":"Thrombopoietin mimetic agents in the management of immune thrombocytopenic purpura","volume":"44","author":"Newland","year":"2007","journal-title":"Semin Hematol"},{"key":"10.1053\/j.seminhematol.2008.12.003_bib63","unstructured":"Bussel JB. Unknown. Blood. In press."},{"key":"10.1053\/j.seminhematol.2008.12.003_bib64","doi-asserted-by":"crossref","first-page":"8a","DOI":"10.1182\/blood.V110.11.2.2","article-title":"Evaluation of AMG 531 efficacy in splenectomized patients with chronic immune thrombocytopenic purpura (ITP) in a randomized placebo-controlled phase 3 study [abstract 2]","volume":"110","author":"Gernsheimer","year":"2007","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2008.12.003_bib65","doi-asserted-by":"crossref","first-page":"173a","DOI":"10.1182\/blood.V110.11.565.565","article-title":"Evaluation of AMG 531 efficacy in nonsplenectomized patients with chronic immune thrombocytopenia purpura (ITP) in a randomized placebo-controlled phase 3 study [abstract 565]","volume":"110","author":"Kuter","year":"2007","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2008.12.003_bib66","doi-asserted-by":"crossref","first-page":"144a","DOI":"10.1182\/blood.V108.11.476.476","article-title":"Long-term dosing of AMG 531 in thrombocytopenic patients with immune thrombocytopenic purpura: 48-week update [abstract 476]","volume":"108","author":"Kuter","year":"2006","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2008.12.003_bib67","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/S0140-6736(08)60203-2","article-title":"Efficacy of romiplostim in patients with chronic immune thrombocytopenic purpura: a double-blind randomised controlled trial","volume":"371","author":"Kuter","year":"2008","journal-title":"Lancet"},{"key":"10.1053\/j.seminhematol.2008.12.003_bib68","doi-asserted-by":"crossref","first-page":"144a","DOI":"10.1182\/blood.V108.11.475.475","article-title":"Analysis of bleeding in patients with immune thrombocytopenic purpura (ITP): a randomized, double-blind, placebo-controlled trial of eltrombopag, an oral platelet growth factor [abstract 475]","volume":"108","author":"Bussel","year":"2006","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2008.12.003_bib69","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1056\/NEJMoa073275","article-title":"Eltrombopag for the treatment of chronic idiopathic thrombocytopenic purpura","volume":"357","author":"Bussel","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1053\/j.seminhematol.2008.12.003_bib70","unstructured":"Bussel JB. Unknown. Lancet. In press."},{"key":"10.1053\/j.seminhematol.2008.12.003_bib71","doi-asserted-by":"crossref","first-page":"145a","DOI":"10.1182\/blood.V108.11.477.477","article-title":"Single and multiple oral doses of AKR-501 (YM477) increases the platelet count in healthy volunteers [abstract 477]","volume":"108","author":"Desjardins","year":"2006","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2008.12.003_bib72","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1097\/MOH.0b013e3282bf6dc2","article-title":"Immune thrombocytopenic purpura in pregnancy","volume":"14","author":"Gernsheimer","year":"2007","journal-title":"Curr Opin Hematol"},{"key":"10.1053\/j.seminhematol.2008.12.003_bib73","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0268-960X(02)00056-5","article-title":"Thrombocytopenia in pregnancy: differential diagnosis, pathogenesis, and management","volume":"17","author":"McCrae","year":"2003","journal-title":"Blood Rev"},{"key":"10.1053\/j.seminhematol.2008.12.003_bib74","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S0037-1963(00)90106-9","article-title":"Management of idiopathic thrombocytopenic purpura in pregnancy","volume":"37","author":"Gill","year":"2000","journal-title":"Semin Hematol"},{"key":"10.1053\/j.seminhematol.2008.12.003_bib75","first-page":"87","article-title":"Idiopathic thrombocytopenic purpura: diagnosis and management","volume":"316","author":"George","year":"1998","journal-title":"Am J Med Sci"},{"key":"10.1053\/j.seminhematol.2008.12.003_bib76","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1016\/S0002-9378(96)70342-3","article-title":"Antiplatelet antibody testing in thrombocytopenic pregnant women","volume":"174","author":"Lescale","year":"1996","journal-title":"Am J Obstet Gynecol"},{"key":"10.1053\/j.seminhematol.2008.12.003_bib77","first-page":"169","article-title":"Maternal antiplatelet antibodies in predicting risk of neonatal thrombocytopenia","volume":"93","author":"Boehlen","year":"1999","journal-title":"Obstet Gynecol"},{"key":"10.1053\/j.seminhematol.2008.12.003_bib78","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1007\/BF02982137","article-title":"Nationwide study of idiopathic thrombocytopenic purpura in pregnant women and the clinical influence on neonates","volume":"75","author":"Fujimura","year":"2002","journal-title":"Int J Hematol"},{"key":"10.1053\/j.seminhematol.2008.12.003_bib79","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1056\/NEJM199007263230404","article-title":"Estimation of the risk of thrombocytopenia in the offspring of pregnant women with presumed immune thrombocytopenic purpura","volume":"323","author":"Samuels","year":"1990","journal-title":"N Engl J Med"},{"key":"10.1053\/j.seminhematol.2008.12.003_bib80","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.ajog.2007.05.046","article-title":"Maternal corticosteroid use and orofacial clefts","volume":"197","author":"Carmichael","year":"2007","journal-title":"Am J Obstet Gynecol"},{"key":"10.1053\/j.seminhematol.2008.12.003_bib81","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1055\/s-2006-954958","article-title":"Long-term effects of fetal and neonatal alloimmune thrombocytopenia and its antenatal treatment on the medical and developmental outcomes of affected children","volume":"23","author":"Ward","year":"2006","journal-title":"Am J Perinatol"},{"key":"10.1053\/j.seminhematol.2008.12.003_bib82","doi-asserted-by":"crossref","first-page":"4306","DOI":"10.1182\/blood-2002-10-3317","article-title":"A retrospective 11-year analysis of obstetric patients with idiopathic thrombocytopenic purpura","volume":"102","author":"Webert","year":"2003","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2008.12.003_bib83","doi-asserted-by":"crossref","first-page":"4573","DOI":"10.1182\/blood.V92.12.4573","article-title":"Pregnancy-associated thrombocytopenia revisited: assessment and follow-up of 50 cases","volume":"92","author":"Ajzenberg","year":"1998","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2008.12.003_bib84","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1182\/asheducation-2001.1.282","article-title":"Platelets: an update on diagnosis and management of thrombocytopenic disorders","author":"McCrae","year":"2001","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"10.1053\/j.seminhematol.2008.12.003_bib85","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1046\/j.1365-2141.2003.04567.x","article-title":"Intravenous anti-D as a treatment for immune thrombocytopenic purpura (ITP) during pregnancy","volume":"123","author":"Michel","year":"2003","journal-title":"Br J Haematol"},{"key":"10.1053\/j.seminhematol.2008.12.003_bib86","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1111\/j.1572-0241.2006.00538.x","article-title":"Azathioprine use during pregnancy: unexpected intrauterine exposure to metabolites","volume":"101","author":"de Boer","year":"2006","journal-title":"Am J Gastroenterol"},{"key":"10.1053\/j.seminhematol.2008.12.003_bib87","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1111\/j.1600-0609.2004.00214.x","article-title":"Safety of rituximab therapy during the first trimester of pregnancy: a case history","volume":"72","author":"Kimby","year":"2004","journal-title":"Eur J Haematol"},{"key":"10.1053\/j.seminhematol.2008.12.003_bib88","first-page":"34","article-title":"Efficacy and safety of a combined rituximab chemotherapy during pregnancy","volume":"19","author":"Herold","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.seminhematol.2008.12.003_bib89","first-page":"271363","article-title":"Rituximab administration in third trimester of pregnancy suppresses neonatal B-cell development","author":"Klink","year":"2008","journal-title":"Clin Dev Immunol"},{"key":"10.1053\/j.seminhematol.2008.12.003_bib90","first-page":"63","article-title":"Immune thrombocytopenic purpura during pregnancy: laparoscopic treatment","volume":"5","author":"Anglin","year":"2001","journal-title":"JSLS"},{"key":"10.1053\/j.seminhematol.2008.12.003_bib91","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/S1701-2163(16)30729-0","article-title":"Laparoscopic splenectomy for the treatment of refractory immune thrombocytopenia in pregnancy","volume":"27","author":"Griffiths","year":"2005","journal-title":"J Obstet Gynaecol Can"},{"key":"10.1053\/j.seminhematol.2008.12.003_bib92","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0037-1963(00)90110-0","article-title":"Splenectomy-sparing strategies for the treatment and long-term maintenance of chronic idiopathic (immune) thrombocytopenic purpura","volume":"37","author":"Bussel","year":"2000","journal-title":"Semin Hematol"},{"key":"10.1053\/j.seminhematol.2008.12.003_bib93","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1146\/annurev.me.28.020177.001503","article-title":"Treatment of idiopathic thrombocytopenic purpura (ITP)","volume":"28","author":"Ahn","year":"1977","journal-title":"Annu Rev Med"},{"key":"10.1053\/j.seminhematol.2008.12.003_bib94","first-page":"605","article-title":"Prevalence and significance of haematological abnormalities in patients with systemic lupus erythematosus","volume":"80","author":"Nossent","year":"1991","journal-title":"Q J Med"},{"key":"10.1053\/j.seminhematol.2008.12.003_bib95","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0049-0172(91)90057-7","article-title":"Lupus erythematosus in the 1980s: a survey of 570 patients","volume":"21","author":"Pistiner","year":"1991","journal-title":"Semin Arthritis Rheum"},{"key":"10.1053\/j.seminhematol.2008.12.003_bib96","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1097\/01.md.0000091181.93122.55","article-title":"Morbidity and mortality in systemic lupus erythematosus during a 10-year period: a comparison of early and late manifestations in a cohort of 1,000 patients","volume":"82","author":"Cervera","year":"2003","journal-title":"Medicine (Baltimore)"},{"key":"10.1053\/j.seminhematol.2008.12.003_bib97","first-page":"1330","article-title":"[Hematological abnormalities in systemic lupus erythematosus and clinical significance thereof: comparative analysis of 236 cases]","volume":"87","author":"Chen","year":"2007","journal-title":"Zhonghua Yi Xue Za Zhi"},{"key":"10.1053\/j.seminhematol.2008.12.003_bib98","doi-asserted-by":"crossref","first-page":"161","DOI":"10.3109\/s10165-008-0029-0","article-title":"Clinical manifestations and clinical syndromes of Filipino patients with systemic lupus erythematosus","volume":"18","author":"Villamin","year":"2008","journal-title":"Mod Rheumatol"},{"key":"10.1053\/j.seminhematol.2008.12.003_bib99","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1078\/0171-2985-00213","article-title":"Clinical and epidemiological aspects in the antiphospholipid syndrome","volume":"207","author":"Cervera","year":"2003","journal-title":"Immunobiology"},{"key":"10.1053\/j.seminhematol.2008.12.003_bib100","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1097\/SMJ.0b013e318046583f","article-title":"Overlapping features of thrombotic thrombocytopenic purpura and systemic lupus erythematosus","volume":"100","author":"George","year":"2007","journal-title":"South Med J"},{"key":"10.1053\/j.seminhematol.2008.12.003_bib101","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1177\/0961203307080636","article-title":"Distinctive clinical features of pediatric systemic lupus erythematosus in three different age classes","volume":"16","author":"Pluchinotta","year":"2007","journal-title":"Lupus"},{"key":"10.1053\/j.seminhematol.2008.12.003_bib102","first-page":"247","article-title":"Intrarenal platelet consumption in the diffuse proliferative nephritis of systemic lupus erythematosus","volume":"49","author":"Clark","year":"1975","journal-title":"Clin Sci Mol Med"},{"key":"10.1053\/j.seminhematol.2008.12.003_bib103","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/j.1365-2249.2006.03122.x","article-title":"Suspects in the tale of lupus-associated thrombocytopenia","volume":"145","author":"Ziakas","year":"2006","journal-title":"Clin Exp Immunol"},{"issue":"Suppl","key":"10.1053\/j.seminhematol.2008.12.003_bib104","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1600-0609.2007.00998.x","article-title":"Epidemiology and pathophysiology of immune thrombocytopenic purpura","author":"Gernsheimer","year":"2008","journal-title":"Eur J Haematol"},{"key":"10.1053\/j.seminhematol.2008.12.003_bib105","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1002\/art.1780360516","article-title":"Treatment of refractory, systemic lupus erythematosus-associated thrombocytopenia with intermittent low-dose intravenous cyclophosphamide","volume":"36","author":"Roach","year":"1993","journal-title":"Arthritis Rheum"},{"key":"10.1053\/j.seminhematol.2008.12.003_bib106","doi-asserted-by":"crossref","first-page":"703","DOI":"10.7326\/0003-4819-108-5-703","article-title":"Danazol for the treatment of refractory autoimmune thrombocytopenia in systemic lupus erythematosus","volume":"108","author":"West","year":"1988","journal-title":"Ann Intern Med"},{"key":"10.1053\/j.seminhematol.2008.12.003_bib107","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1136\/ard.51.10.1149","article-title":"Treatment of severe thrombocytopenia in systemic lupus erythematosus with intravenous gammaglobulin","volume":"51","author":"ter Borg","year":"1992","journal-title":"Ann Rheum Dis"},{"key":"10.1053\/j.seminhematol.2008.12.003_bib108","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/j.1600-0609.1973.tb00035.x","article-title":"Evaluation of azathioprine in autoimmune thrombocytopenia and lupus erythematosus","volume":"10","author":"Goebel","year":"1973","journal-title":"Scand J Haematol"},{"key":"10.1053\/j.seminhematol.2008.12.003_bib109","first-page":"75","article-title":"Treatment of severe immune thrombocytopenia associated with systemic lupus erythematosus: 59 cases","volume":"29","author":"Arnal","year":"2002","journal-title":"J Rheumatol"},{"key":"10.1053\/j.seminhematol.2008.12.003_bib110","first-page":"458","article-title":"[Rituximab for treatment of patients with systemic autoimmune diseases]","volume":"128","author":"Garcia Hernandez","year":"2007","journal-title":"Med Clin (Barc)"},{"key":"10.1053\/j.seminhematol.2008.12.003_bib111","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0151-9638(06)70845-6","article-title":"[Rituximab treatment for immune thrombocytopenia associated with systemic lupus erythematosus]","volume":"133","author":"Lehembre","year":"2006","journal-title":"Ann Dermatol Venereol"},{"key":"10.1053\/j.seminhematol.2008.12.003_bib112","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1002\/ajh.20212","article-title":"Long-term remission from life-threatening hypercoagulable state associated with lupus anticoagulant (LA) following rituximab therapy","volume":"78","author":"Ahn","year":"2005","journal-title":"Am J Hematol"},{"key":"10.1053\/j.seminhematol.2008.12.003_bib113","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1078\/0171-2985-00200","article-title":"Effective B cell depletion with rituximab in the treatment of autoimmune diseases","volume":"206","author":"Kneitz","year":"2002","journal-title":"Immunobiology"},{"key":"10.1053\/j.seminhematol.2008.12.003_bib114","first-page":"5","article-title":"Antiphospholipid antibodies: a review","volume":"7","author":"Harris","year":"1984","journal-title":"Eur J Rheumatol Inflamm"},{"key":"10.1053\/j.seminhematol.2008.12.003_bib115","doi-asserted-by":"crossref","first-page":"2717","DOI":"10.1182\/blood-2002-11-3334","article-title":"Anti-beta 2-glycoprotein I, antiprothrombin antibodies, and the risk of thrombosis in the antiphospholipid syndrome","volume":"102","author":"Galli","year":"2003","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2008.12.003_bib116","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1046\/j.1365-2141.2002.03729.x","article-title":"Detection of lupus anticoagulant identifies patients with autoimmune haemolytic anaemia at increased risk for venous thromboembolism","volume":"118","author":"Pullarkat","year":"2002","journal-title":"Br J Haematol"},{"key":"10.1053\/j.seminhematol.2008.12.003_bib117","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1182\/blood-2002-02-0441","article-title":"Lupus anticoagulants are stronger risk factors for thrombosis than anticardiolipin antibodies in the antiphospholipid syndrome: a systematic review of the literature","volume":"101","author":"Galli","year":"2003","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2008.12.003_bib118","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1111\/j.1538-7836.2005.01485.x","article-title":"Lupus anticoagulants and the risk of a first episode of deep venous thrombosis","volume":"3","author":"De Groot","year":"2005","journal-title":"J Thromb Haemost"},{"key":"10.1053\/j.seminhematol.2008.12.003_bib119","doi-asserted-by":"crossref","first-page":"4203","DOI":"10.1182\/blood.V84.12.4203.bloodjournal84124203","article-title":"Prevalence and clinical significance of elevated antiphospholipid antibodies in patients with idiopathic thrombocytopenic purpura","volume":"84","author":"Stasi","year":"1994","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2008.12.003_bib120","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1182\/blood.V98.6.1760","article-title":"Antiphospholipid antibodies and antiphospholipid syndrome in patients presenting with immune thrombocytopenic purpura: a prospective cohort study","volume":"98","author":"Diz-Kucukkaya","year":"2001","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2008.12.003_bib121","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1007\/BF02724290","article-title":"Lupus anticoagulant in immune thrombocytopenic purpura","volume":"71","author":"Dash","year":"2004","journal-title":"Indian J Pediatr"},{"key":"10.1053\/j.seminhematol.2008.12.003_bib122","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1538-7836.2006.01753.x","article-title":"International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)","volume":"4","author":"Miyakis","year":"2006","journal-title":"J Thromb Haemost"},{"key":"10.1053\/j.seminhematol.2008.12.003_bib123","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1055\/s-0038-1642484","article-title":"Anti-glycoprotein Ib\/IX and IIb\/IIIa antibodies in patients with antiphospholipid antibodies","volume":"71","author":"Galli","year":"1994","journal-title":"Thromb Haemost"},{"key":"10.1053\/j.seminhematol.2008.12.003_bib124","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1046\/j.1365-2141.1997.2243038.x","article-title":"Anti-platelet antibodies in patients with systemic lupus erythematosus and the primary antiphospholipid antibody syndrome: their relationship with the observed thrombocytopenia","volume":"98","author":"Macchi","year":"1997","journal-title":"Br J Haematol"},{"key":"10.1053\/j.seminhematol.2008.12.003_bib125","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1046\/j.1365-2141.1997.3063123.x","article-title":"Specific antiplatelet glycoprotein autoantibodies are associated with the thrombocytopenia of primary antiphospholipid syndrome","volume":"98","author":"Godeau","year":"1997","journal-title":"Br J Haematol"},{"key":"10.1053\/j.seminhematol.2008.12.003_bib126","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1111\/j.1600-0609.1994.tb00195.x","article-title":"Specific antiplatelet autoantibodies in patients with antiphospholipid antibodies and thrombocytopenia","volume":"53","author":"Fabris","year":"1994","journal-title":"Eur J Haematol"},{"key":"10.1053\/j.seminhematol.2008.12.003_bib127","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1055\/s-0037-1614491","article-title":"Platelet activation induced by combined effects of anticardiolipin and lupus anticoagulant IgG antibodies in patients with systemic lupus erythematosus\u2014possible association with thrombotic and thrombocytopenic complications","volume":"81","author":"Nojima","year":"1999","journal-title":"Thromb Haemost"},{"key":"10.1053\/j.seminhematol.2008.12.003_bib128","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1002\/ajh.1182","article-title":"Correction of thrombocytopenia with aspirin in the primary antiphospholipid syndrome","volume":"68","author":"Alliot","year":"2001","journal-title":"Am J Hematol"},{"key":"10.1053\/j.seminhematol.2008.12.003_bib129","first-page":"1359","article-title":"Correction of thrombocytopenia with small dose aspirin in the primary antiphospholipid syndrome","volume":"16","author":"Alarcon-Segovia","year":"1989","journal-title":"J Rheumatol"},{"key":"10.1053\/j.seminhematol.2008.12.003_bib130","first-page":"803","article-title":"Multiple complications of the antiphospholipid syndrome with apparent response to aspirin therapy","volume":"19","author":"Cohen","year":"1992","journal-title":"J Rheumatol"},{"key":"10.1053\/j.seminhematol.2008.12.003_bib131","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/0049-3848(92)90020-B","article-title":"Anticardiolipin antibodies in heparin-associated thrombocytopenia","volume":"67","author":"Gruel","year":"1992","journal-title":"Thromb Res"},{"key":"10.1053\/j.seminhematol.2008.12.003_bib132","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1055\/s-0038-1650316","article-title":"The pathogenesis of the antiphospholipid syndrome: a hypothesis based on parallelisms with heparin-induced thrombocytopenia","volume":"75","author":"Arnout","year":"1996","journal-title":"Thromb Haemost"},{"key":"10.1053\/j.seminhematol.2008.12.003_bib133","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1093\/rheumatology\/38.9.848","article-title":"Splenectomy for refractory thrombocytopenia in the antiphospholipid syndrome","volume":"38","author":"Galindo","year":"1999","journal-title":"Rheumatology (Oxford)"},{"key":"10.1053\/j.seminhematol.2008.12.003_bib134","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.ejim.2004.03.005","article-title":"Thrombotic risk in patients submitted to splenectomy for systemic lupus erythematosus and antiphospholipid antibody syndrome-related thrombocytopenia","volume":"15","author":"Delgado Alves","year":"2004","journal-title":"Eur J Intern Med"},{"key":"10.1053\/j.seminhematol.2008.12.003_bib135","first-page":"ECR34","article-title":"Sustained response to rituximab of autoimmune hemolytic anemia associated with antiphospholipid syndrome","volume":"89","author":"Erdozain","year":"2004","journal-title":"Haematologica"},{"key":"10.1053\/j.seminhematol.2008.12.003_bib136","first-page":"355","article-title":"Rituximab treatment for resistant antiphospholipid syndrome","volume":"33","author":"Rubenstein","year":"2006","journal-title":"J Rheumatol"},{"key":"10.1053\/j.seminhematol.2008.12.003_bib137","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1136\/bmj.2.4843.976","article-title":"Thyrotoxicosis complicated by thrombocytopenic purpura","volume":"2","author":"Caldwell","year":"1953","journal-title":"Br Med J"},{"key":"10.1053\/j.seminhematol.2008.12.003_bib138","doi-asserted-by":"crossref","first-page":"27","DOI":"10.7326\/0003-4819-94-1-27","article-title":"Easy bruising, thrombocytopenia, and elevated platelet immunoglobulin G in Graves' disease and Hashimoto's thyroiditis","volume":"94","author":"Hymes","year":"1981","journal-title":"Ann Intern Med"},{"key":"10.1053\/j.seminhematol.2008.12.003_bib139","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1080\/09537100801894651","article-title":"Thyroid and celiac diseases autoantibodies in patients with adult chronic idiopathic thrombocytopenic purpura","volume":"19","author":"Altintas","year":"2008","journal-title":"Platelets"},{"key":"10.1053\/j.seminhematol.2008.12.003_bib140","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1046\/j.1365-2249.1998.00677.x","article-title":"Autoimmune thrombocytopenia (AITP) and thyroid autoimmune disease (TAD): overlapping syndromes?","volume":"113","author":"Cordiano","year":"1998","journal-title":"Clin Exp Immunol"},{"key":"10.1053\/j.seminhematol.2008.12.003_bib141","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1210\/jcem-70-2-491","article-title":"Platelets in hyperthyroidism: studies on platelet counts, mean platelet volume, 111-indium-labeled platelet kinetics, and platelet-associated immunoglobulins G and M","volume":"70","author":"Panzer","year":"1990","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1053\/j.seminhematol.2008.12.003_bib142","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1046\/j.1365-2141.1998.00765.x","article-title":"Elevated numbers of reticulated platelets in hyperthyroidism: direct evidence for an increase of thrombopoiesis","volume":"101","author":"Stiegler","year":"1998","journal-title":"Br J Haematol"},{"key":"10.1053\/j.seminhematol.2008.12.003_bib143","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1002\/ajh.20299","article-title":"Prevalence of elevated antithyroid antibodies and antinuclear antibodies in children with immune thrombocytopenic purpura","volume":"79","author":"Pratt","year":"2005","journal-title":"Am J Hematol"},{"key":"10.1053\/j.seminhematol.2008.12.003_bib144","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/(SICI)1096-8652(200005)64:1<73::AID-AJH14>3.0.CO;2-U","article-title":"Autoimmune thyroid disease and antiphospholipid antibodies","volume":"64","author":"Nabriski","year":"2000","journal-title":"Am J Hematol"},{"key":"10.1053\/j.seminhematol.2008.12.003_bib145","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1001\/archinte.1982.00340210052013","article-title":"Variable presentation of thrombocytopenia in Graves' disease","volume":"142","author":"Adrouny","year":"1982","journal-title":"Arch Intern Med"},{"key":"10.1053\/j.seminhematol.2008.12.003_bib146","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1001\/archinte.1997.00440300155015","article-title":"Graves disease associated with autoimmune thrombocytopenic purpura","volume":"157","author":"Hofbauer","year":"1997","journal-title":"Arch Intern Med"},{"key":"10.1053\/j.seminhematol.2008.12.003_bib147","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1111\/j.1600-0609.2004.00341.x","article-title":"Improvement of idiopathic thrombocytopenic purpura by antithyroid therapy","volume":"74","author":"Sugimoto","year":"2005","journal-title":"Eur J Haematol"},{"key":"10.1053\/j.seminhematol.2008.12.003_bib148","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1136\/jcp.2004.016543","article-title":"Resolution of chronic severe refractory thrombocytopenia after treatment of hypothyroidism","volume":"57","author":"Bowles","year":"2004","journal-title":"J Clin Pathol"},{"key":"10.1053\/j.seminhematol.2008.12.003_bib149","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/j.jaci.2007.08.053","article-title":"Primary immunodeficiency diseases: an update from the International Union of Immunological Societies Primary Immunodeficiency Diseases Classification Committee","volume":"120","author":"Geha","year":"2007","journal-title":"J Allergy Clin Immunol"},{"key":"10.1053\/j.seminhematol.2008.12.003_bib150","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S0140-6736(08)61199-X","article-title":"Common variable immunodeficiency: a new look at an old disease","volume":"372","author":"Park","year":"2008","journal-title":"Lancet"},{"key":"10.1053\/j.seminhematol.2008.12.003_bib151","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1006\/clim.1999.4725","article-title":"Common variable immunodeficiency: clinical and immunological features of 248 patients","volume":"92","author":"Cunningham-Rundles","year":"1999","journal-title":"Clin Immunol"},{"key":"10.1053\/j.seminhematol.2008.12.003_bib152","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1007\/s10875-007-9075-1","article-title":"Long-term follow-up and outcome of a large cohort of patients with common variable immunodeficiency","volume":"27","author":"Quinti","year":"2007","journal-title":"J Clin Immunol"},{"key":"10.1053\/j.seminhematol.2008.12.003_bib153","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1097\/01.md.0000133624.65946.40","article-title":"Autoimmune thrombocytopenic purpura and common variable immunodeficiency: analysis of 21 cases and review of the literature","volume":"83","author":"Michel","year":"2004","journal-title":"Medicine (Baltimore)"},{"key":"10.1053\/j.seminhematol.2008.12.003_bib154","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jaut.2005.04.006","article-title":"Treatment and outcome of autoimmune hematologic disease in common variable immunodeficiency (CVID)","volume":"25","author":"Wang","year":"2005","journal-title":"J Autoimmun"},{"issue":"Suppl 1","key":"10.1053\/j.seminhematol.2008.12.003_bib155","doi-asserted-by":"crossref","first-page":"S42","DOI":"10.1007\/s10875-008-9182-7","article-title":"Autoimmune manifestations in common variable immunodeficiency","volume":"28","author":"Cunningham-Rundles","year":"2008","journal-title":"J Clin Immunol"},{"key":"10.1053\/j.seminhematol.2008.12.003_bib156","first-page":"169","article-title":"Presence of idiopathic thrombocytopenic purpura and autoimmune hemolytic anemia in the patients with common variable immunodeficiency","volume":"7","author":"Ramyar","year":"2008","journal-title":"Iran J Allergy Asthma Immunol"},{"key":"10.1053\/j.seminhematol.2008.12.003_bib157","doi-asserted-by":"crossref","first-page":"2516","DOI":"10.1002\/1521-4141(200009)30:9<2516::AID-IMMU2516>3.0.CO;2-Z","article-title":"Study of the B cell memory compartment in common variable immunodeficiencyResolution of chronic severe refractory thrombocytopenia after treatment of hypothyroidismd","volume":"30","author":"Brouet","year":"2000","journal-title":"Eur J Immunol"},{"key":"10.1053\/j.seminhematol.2008.12.003_bib158","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1006\/clim.2001.5197","article-title":"Absence of memory B cells in patients with common variable immunodeficiency","volume":"103","author":"Agematsu","year":"2002","journal-title":"Clin Immunol"},{"key":"10.1053\/j.seminhematol.2008.12.003_bib159","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1182\/blood.V99.5.1544","article-title":"Severe deficiency of switched memory B cells (CD27(+)IgM(-)IgD(-)) in subgroups of patients with common variable immunodeficiency: a new approach to classify a heterogeneous disease","volume":"99","author":"Warnatz","year":"2002","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2008.12.003_bib160","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1023\/A:1025373601374","article-title":"Common variable immunodeficiency patient classification based on impaired B cell memory differentiation correlates with clinical aspects","volume":"23","author":"Piqueras","year":"2003","journal-title":"J Clin Immunol"},{"key":"10.1053\/j.seminhematol.2008.12.003_bib161","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1182\/blood-2007-06-091744","article-title":"The EUROclass trial: defining subgroups in common variable immunodeficiency","volume":"111","author":"Wehr","year":"2008","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2008.12.003_bib162","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1182\/blood-2007-11-124545","article-title":"Common variable immunodeficiency disorders: division into distinct clinical phenotypes","volume":"112","author":"Chapel","year":"2008","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2008.12.003_bib163","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.clim.2005.03.019","article-title":"Immune competence and switched memory B cells in common variable immunodeficiency","volume":"116","author":"Ko","year":"2005","journal-title":"Clin Immunol"},{"key":"10.1053\/j.seminhematol.2008.12.003_bib164","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.clim.2006.05.003","article-title":"Memory switched B cell percentage and not serum immunoglobulin concentration is associated with clinical complications in children and adults with specific antibody deficiency and common variable immunodeficiency","volume":"120","author":"Alachkar","year":"2006","journal-title":"Clin Immunol"},{"key":"10.1053\/j.seminhematol.2008.12.003_bib165","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1056\/NEJMra055446","article-title":"Regulation of immune responses by T cells","volume":"354","author":"Jiang","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1053\/j.seminhematol.2008.12.003_bib166","doi-asserted-by":"crossref","first-page":"3932","DOI":"10.4049\/jimmunol.178.6.3932","article-title":"Unravelling the complexity of T cell abnormalities in common variable immunodeficiency","volume":"178","author":"Giovannetti","year":"2007","journal-title":"J Immunol"},{"key":"10.1053\/j.seminhematol.2008.12.003_bib167","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1111\/j.1365-2249.2006.03314.x","article-title":"Low numbers of regulatory T cells in common variable immunodeficiency: association with chronic inflammation in vivo","volume":"147","author":"Fevang","year":"2007","journal-title":"Clin Exp Immunol"},{"key":"10.1053\/j.seminhematol.2008.12.003_bib168","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1111\/j.1365-2796.2008.01971.x","article-title":"Revisiting human primary immunodeficiencies","volume":"264","author":"Casanova","year":"2008","journal-title":"J Intern Med"},{"key":"10.1053\/j.seminhematol.2008.12.003_bib169","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaci.2008.08.038","article-title":"Is it necessary to identify molecular defects in primary immunodeficiency disease?","author":"Notarangelo","year":"2008","journal-title":"J Allergy Clin Immunol"},{"key":"10.1053\/j.seminhematol.2008.12.003_bib170","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1016\/j.jaci.2007.10.001","article-title":"Transmembrane activator and calcium-modulating cyclophilin ligand interactor mutations in common variable immunodeficiency: clinical and immunologic outcomes in heterozygotes","volume":"120","author":"Zhang","year":"2007","journal-title":"J Allergy Clin Immunol"},{"key":"10.1053\/j.seminhematol.2008.12.003_bib171","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1054\/blre.2001.0185","article-title":"Hematologic complications of primary immune deficiencies","volume":"16","author":"Cunningham-Rundles","year":"2002","journal-title":"Blood Rev"},{"key":"10.1053\/j.seminhematol.2008.12.003_bib172","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1196\/annals.1361.111","article-title":"Partial response to anti-CD20 monoclonal antibody treatment of severe immune thrombocytopenic purpura in a patient with common variable immunodeficiency","volume":"1051","author":"Carbone","year":"2005","journal-title":"Ann N Y Acad Sci"},{"key":"10.1053\/j.seminhematol.2008.12.003_bib173","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1002\/ajh.20619","article-title":"Efficiency of rituximab in the treatment of autoimmune thrombocytopenic purpura associated with common variable immunodeficiency","volume":"81","author":"Mahevas","year":"2006","journal-title":"Am J Hematol"},{"key":"10.1053\/j.seminhematol.2008.12.003_bib174","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1001\/archinte.1951.03810010058005","article-title":"Primary thrombocytopenic purpura and acquired hemolytic anemia; evidence for a common etiology","volume":"87","author":"Evans","year":"1951","journal-title":"AMA Arch Intern Med"},{"key":"10.1053\/j.seminhematol.2008.12.003_bib175","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7326\/0003-4819-52-1-1","article-title":"Systemic lupus erytematosus after \u201cidiopathic\u201d thrombocytopenic purpura: a review","volume":"52","author":"Rabinowitz","year":"1960","journal-title":"Ann Intern Med"},{"key":"10.1053\/j.seminhematol.2008.12.003_bib176","first-page":"611","article-title":"Occurrence of both hemolytic anemia and thrombocytopenic purpura (Evans' syndrome) in systemic lupus erythematosus","volume":"15","author":"Deleze","year":"1988","journal-title":"J Rheumatol"},{"key":"10.1053\/j.seminhematol.2008.12.003_bib177","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/BF02041395","article-title":"Hemocytopenia as initial manifestation of systemic lupus erythematosus","volume":"2","author":"Lavalle","year":"1983","journal-title":"Clin Rheumatol"},{"key":"10.1053\/j.seminhematol.2008.12.003_bib178","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1182\/blood-2006-01-010124","article-title":"Rapamycin improves lymphoproliferative disease in murine autoimmune lymphoproliferative syndrome (ALPS)","volume":"108","author":"Teachey","year":"2006","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2008.12.003_bib179","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1111\/j.1365-2141.2005.05809.x","article-title":"Management of Evans syndrome","volume":"132","author":"Norton","year":"2006","journal-title":"Br J Haematol"},{"key":"10.1053\/j.seminhematol.2008.12.003_bib180","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1097\/00043426-199709000-00005","article-title":"Evans syndrome: results of a national survey","volume":"19","author":"Mathew","year":"1997","journal-title":"J Pediatr Hematol Oncol"},{"key":"10.1053\/j.seminhematol.2008.12.003_bib181","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1097\/00043426-199511000-00003","article-title":"Evans syndrome","volume":"17","author":"Scaradavou","year":"1995","journal-title":"J Pediatr Hematol Oncol"},{"key":"10.1053\/j.seminhematol.2008.12.003_bib182","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1007\/s002770000251","article-title":"Effective treatment with rituximab in a patient with refractory prolymphocytoid transformed B-chronic lymphocytic leukemia and Evans syndrome","volume":"80","author":"Seipelt","year":"2001","journal-title":"Ann Hematol"},{"key":"10.1053\/j.seminhematol.2008.12.003_bib183","doi-asserted-by":"crossref","first-page":"3857","DOI":"10.1182\/blood-2002-11-3547","article-title":"Rituximab for the treatment of refractory autoimmune hemolytic anemia in children","volume":"101","author":"Zecca","year":"2003","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2008.12.003_bib184","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.3324\/haematol.11540","article-title":"Rituximab therapy for childhood Evans syndrome","volume":"92","author":"Bader-Meunier","year":"2007","journal-title":"Haematologica"},{"key":"10.1053\/j.seminhematol.2008.12.003_bib185","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1080\/03009740802068599","article-title":"A case of Evans syndrome combined with systemic lupus erythematosus successfully treated with rituximab","volume":"37","author":"Kittaka","year":"2008","journal-title":"Scand J Rheumatol"},{"key":"10.1053\/j.seminhematol.2008.12.003_bib186","doi-asserted-by":"crossref","first-page":"886","DOI":"10.7326\/0003-4819-129-11_Part_1-199812010-00009","article-title":"Drug-induced thrombocytopenia: a systematic review of published case reports","volume":"129","author":"George","year":"1998","journal-title":"Ann Intern Med"},{"key":"10.1053\/j.seminhematol.2008.12.003_bib187","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1002\/j.1875-9114.1998.tb03148.x","article-title":"Antiepileptics and blood dyscrasias: a cohort study","volume":"18","author":"Blackburn","year":"1998","journal-title":"Pharmacotherapy"},{"key":"10.1053\/j.seminhematol.2008.12.003_bib188","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1007\/s11882-002-0035-9","article-title":"Antiepileptic hypersensitivity syndrome: clinicians beware and be aware","volume":"2","author":"Bessmertny","year":"2002","journal-title":"Curr Allergy Asthma Rep"},{"key":"10.1053\/j.seminhematol.2008.12.003_bib189","doi-asserted-by":"crossref","first-page":"3846","DOI":"10.1182\/blood.V97.12.3846","article-title":"Immune thrombocytopenia resulting from sensitivity to metabolites of naproxen and acetaminophen","volume":"97","author":"Bougie","year":"2001","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2008.12.003_bib190","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1056\/NEJMra066469","article-title":"Drug-induced immune thrombocytopenia","volume":"357","author":"Aster","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1053\/j.seminhematol.2008.12.003_bib191","doi-asserted-by":"crossref","first-page":"90","DOI":"10.7326\/0003-4819-120-1-199401010-00025","article-title":"Quinine-induced pancytopenia and coagulopathy","volume":"120","author":"Schmitt","year":"1994","journal-title":"Ann Intern Med"},{"key":"10.1053\/j.seminhematol.2008.12.003_bib192","first-page":"409","article-title":"Heparin induced thrombocytopenia with thrombotic and hemorrhagic manifestations","volume":"136","author":"Rhodes","year":"1973","journal-title":"Surg Gynecol Obstet"},{"key":"10.1053\/j.seminhematol.2008.12.003_bib193","doi-asserted-by":"crossref","first-page":"9S","DOI":"10.1378\/chest.127.2_suppl.9S","article-title":"The pathophysiology of heparin-induced thrombocytopenia: biological basis for treatment","volume":"127","author":"Kelton","year":"2005","journal-title":"Chest"},{"key":"10.1053\/j.seminhematol.2008.12.003_bib194","doi-asserted-by":"crossref","first-page":"311S","DOI":"10.1378\/chest.126.3_suppl.311S","article-title":"Heparin-induced thrombocytopenia: recognition, treatment, and prevention: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy","volume":"126","author":"Warkentin","year":"2004","journal-title":"Chest"},{"key":"10.1053\/j.seminhematol.2008.12.003_bib195","doi-asserted-by":"crossref","first-page":"2937","DOI":"10.1182\/blood-2005-11-012450","article-title":"Gender imbalance and risk factor interactions in heparin-induced thrombocytopenia","volume":"108","author":"Warkentin","year":"2006","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2008.12.003_bib196","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1160\/TH04-12-0825","article-title":"Clinical features of heparin-induced thrombocytopenia including risk factors for thrombosis","volume":"94","author":"Greinacher","year":"2005","journal-title":"Thromb Haemost"},{"key":"10.1053\/j.seminhematol.2008.12.003_bib197","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1182\/asheducation-2004.1.390","article-title":"Congenital and acquired thrombocytopenia","author":"Cines","year":"2004","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"10.1053\/j.seminhematol.2008.12.003_bib198","doi-asserted-by":"crossref","first-page":"R161","DOI":"10.1186\/cc5100","article-title":"Outcome of postoperative critically ill patients with heparin-induced thrombocytopenia: an observational retrospective case-control study","volume":"10","author":"Gettings","year":"2006","journal-title":"Crit Care"},{"key":"10.1053\/j.seminhematol.2008.12.003_bib199","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1001\/archinternmed.2007.65","article-title":"Incidence and prognostic significance of thrombocytopenia in patients treated with prolonged heparin therapy","volume":"168","author":"Oliveira","year":"2008","journal-title":"Arch Intern Med"},{"key":"10.1053\/j.seminhematol.2008.12.003_bib200","doi-asserted-by":"crossref","first-page":"340S","DOI":"10.1378\/chest.08-0677","article-title":"Treatment and prevention of heparin-induced thrombocytopenia: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition)","volume":"133","author":"Warkentin","year":"2008","journal-title":"Chest"},{"key":"10.1053\/j.seminhematol.2008.12.003_bib201","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1093\/ajcp\/111.5.700","article-title":"Decision analysis for use of platelet aggregation test, carbon 14-serotonin release assay, and heparin-platelet factor 4 enzyme-linked immunosorbent assay for diagnosis of heparin-induced thrombocytopenia","volume":"111","author":"Pouplard","year":"1999","journal-title":"Am J Clin Pathol"},{"key":"10.1053\/j.seminhematol.2008.12.003_bib202","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1001\/archinte.164.4.361","article-title":"Treatment of heparin-induced thrombocytopenia: a critical review","volume":"164","author":"Hirsh","year":"2004","journal-title":"Arch Intern Med"},{"key":"10.1053\/j.seminhematol.2008.12.003_bib203","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/S0002-9343(96)00258-6","article-title":"A 14-year study of heparin-induced thrombocytopenia","volume":"101","author":"Warkentin","year":"1996","journal-title":"Am J Med"},{"key":"10.1053\/j.seminhematol.2008.12.003_bib204","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1002\/ajh.21273","article-title":"Delayed-onset HIT caused by low-molecular-weight heparin manifesting during fondaparinux prophylaxis","volume":"83","author":"Alsaleh","year":"2009","journal-title":"Am J Hematol"},{"key":"10.1053\/j.seminhematol.2008.12.003_bib205","doi-asserted-by":"crossref","first-page":"27S","DOI":"10.1378\/chest.127.2_suppl.27S","article-title":"Transition to an oral anticoagulant in patients with heparin-induced thrombocytopenia","volume":"127","author":"Bartholomew","year":"2005","journal-title":"Chest"},{"key":"10.1053\/j.seminhematol.2008.12.003_bib206","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1016\/j.athoracsur.2003.09.034","article-title":"Heparin-induced thrombocytopenia and cardiac surgery","volume":"76","author":"Warkentin","year":"2003","journal-title":"Ann Thorac Surg"}],"container-title":["Seminars in Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0037196308002023?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0037196308002023?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T06:19:45Z","timestamp":1758521985000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0037196308002023"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,1]]},"references-count":206,"alternative-id":["S0037196308002023"],"URL":"https:\/\/doi.org\/10.1053\/j.seminhematol.2008.12.003","relation":{},"ISSN":["0037-1963"],"issn-type":[{"value":"0037-1963","type":"print"}],"subject":[],"published":{"date-parts":[[2009,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Therapeutic Approaches to Secondary Immune Thrombocytopenic Purpura","name":"articletitle","label":"Article Title"},{"value":"Seminars in Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.seminhematol.2008.12.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}